tiprankstipranks
Trending News
More News >

MedSci Healthcare Issues Profit Warning Amid Expansion Efforts

Story Highlights
  • MedSci Healthcare anticipates a profit decrease due to increased expenses and revenue decline.
  • The company remains profitable and is focused on international expansion for future growth.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

MedSci Healthcare Holdings Limited ( (HK:2415) ) just unveiled an update.

MedSci Healthcare Holdings Limited has issued a profit warning, anticipating a decrease in net profit to not more than RMB30.0 million for the year ending December 2024, compared to RMB55.0 million in the previous year. This decline is attributed to increased administrative expenses from share awards, absence of fair value gains on shares, reduced revenue due to customer project delays, and costs associated with international expansion. Despite these challenges, the company remains profitable and is committed to optimizing operations for sustainable growth.

More about MedSci Healthcare Holdings Limited

MedSci Healthcare Holdings Limited operates in the healthcare industry, focusing on providing medical and healthcare services. The company is actively pursuing international expansion, targeting markets in Japan, Singapore, and Vietnam to enhance its global presence.

YTD Price Performance: 27.27%

Average Trading Volume: 675,057

Technical Sentiment Consensus Rating: Hold

Current Market Cap: HK$627.7M

Learn more about 2415 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App